Patents by Inventor Kellie Glenn

Kellie Glenn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11738003
    Abstract: There is provided a new dosage regimen for Compound A which maximizes anti-tumor activity while maintaining acceptable toxicity levels.
    Type: Grant
    Filed: November 18, 2020
    Date of Patent: August 29, 2023
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Kellie Glenn, Brian Higgins, Gwen Nichols, Kathryn Packman
  • Publication number: 20210069149
    Abstract: There is provided a new dosage regimen for Compound A which maximizes anti-tumor activity while maintaining acceptable toxicity levels.
    Type: Application
    Filed: November 18, 2020
    Publication date: March 11, 2021
    Inventors: Kellie Glenn, Brian Higgins, Gwen Nichols, Kathryn Packman